Department of Biomedicine, University of Bergen, Bergen, Norway.
Mol Cell Endocrinol. 2013 May 22;371(1-2):133-9. doi: 10.1016/j.mce.2012.12.028. Epub 2013 Jan 8.
The nuclear receptor steroidogenic factor 1 (SF-1) is expressed in a precise time and cell-specific pattern in the endocrine system. Three intronic enhancers and one upstream enhancer, which are required for controlling the restricted expression of SF-1, have been identified in the mouse gene encoding SF-1. In recent years, efforts from several laboratories have established that expression of SF-1 is controlled by DNA methylation. CpG-sites are found in the basal promoter as well as in the intronic enhancers, and the methylation status of these genomic regions nearly perfectly correlates with their transcriptional activity such that they are hypomethylated in tissues where they are active, and generally hypermethylated in tissues where they are not active. This review summarizes the present knowledge of how tissue differentially methylated regions control the transcriptional activity of the SF-1 gene, and how irregularities in the methylation pattern can contribute to disease development.
核受体类固醇生成因子 1(SF-1)在内分泌系统中以精确的时间和细胞特异性模式表达。已经在编码 SF-1 的小鼠基因中鉴定出三个内含子增强子和一个上游增强子,这些增强子对于控制 SF-1 的受限表达是必需的。近年来,来自几个实验室的努力已经证实 SF-1 的表达受 DNA 甲基化的控制。CpG 位点存在于基础启动子和内含子增强子中,这些基因组区域的甲基化状态与它们的转录活性几乎完全相关,即它们在活性组织中呈低甲基化,而在非活性组织中通常呈高甲基化。这篇综述总结了目前关于组织差异甲基化区域如何控制 SF-1 基因的转录活性,以及甲基化模式的不规则性如何导致疾病发展的知识。